We design tailored strategies based on your specific services, patient demographics, and growth goals
Unfortunately, Ozempic and drugs like it have recently been connected to serious, long-term conditions
News provided by Eli Lilly and Company Dec 11, 2025, 06:45 ET In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function, with more than 1 out of 8 retatrutide-treated patients completely free from knee pain at the end of the trial Seven additional Phase 3 trials evaluating the investigational once-weekly treatment in obesity and type 2 diabetes are expected to complete in 2026 INDIANAPOLIS, Dec
Clinical trials show that Wegovy is more effective than Ozempic at helping patients lose weight
L-arginine + L-ornithine 500mg/200mg is 100% suitable for a vegan diet
LA is the first pharmacological treatment ever tested in phase III clinical trials for celiac disease (5)